A
45.12
-0.36 (-0.79%)
| Previous Close | 45.48 |
| Open | 45.32 |
| Volume | 164,243 |
| Avg. Volume (3M) | 388,317 |
| Market Cap | 2,137,557,248 |
| Price / Earnings (Forward) | 62.89 |
| Price / Sales | 4.62 |
| Price / Book | 4.77 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | -5.49% |
| Operating Margin (TTM) | -0.69% |
| Diluted EPS (TTM) | -0.510 |
| Quarterly Revenue Growth (YOY) | 1.60% |
| Total Debt/Equity (MRQ) | 123.15% |
| Current Ratio (MRQ) | 5.53 |
| Operating Cash Flow (TTM) | 10.78 M |
| Levered Free Cash Flow (TTM) | -14.03 M |
| Return on Assets (TTM) | 1.54% |
| Return on Equity (TTM) | -7.26% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Artivion, Inc. | Bullish | Bullish |
AIStockmoo Score
-0.1
| Analyst Consensus | 4.0 |
| Insider Activity | -3.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.10 |
|
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company’s products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 5.01% |
| % Held by Institutions | 98.14% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Perceptive Advisors Llc | 30 Sep 2025 | 2,020,000 |
| Juniper Investment Company, Llc | 30 Sep 2025 | 1,333,692 |
| Fred Alger Management, Llc | 30 Sep 2025 | 1,317,250 |
| Next Century Growth Investors Llc | 30 Sep 2025 | 1,048,486 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 58.00 (Needham, 28.55%) | Buy |
| Median | 51.00 (13.03%) | |
| Low | 46.00 (Stifel, 1.95%) | Buy |
| Average | 51.00 (13.03%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 43.37 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Canaccord Genuity | 07 Nov 2025 | 51.00 (13.03%) | Buy | 44.87 |
| 29 Sep 2025 | 50.00 (10.82%) | Buy | 42.04 | |
| Citizens | 07 Nov 2025 | 53.00 (17.46%) | Buy | 44.87 |
| Needham | 07 Nov 2025 | 58.00 (28.55%) | Buy | 44.87 |
| JMP Securities | 10 Oct 2025 | 47.00 (4.17%) | Buy | 40.20 |
| Stifel | 29 Sep 2025 | 46.00 (1.95%) | Buy | 42.04 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| HOLLOWAY JEAN F | - | 45.48 | -7,315 | -332,686 |
| HORTON AMY | - | 44.07 | -4,572 | -201,488 |
| MACKIN JAMES P | - | 45.43 | -61,842 | -2,809,173 |
| Aggregate Net Quantity | -73,729 | |||
| Aggregate Net Value ($) | -3,343,347 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 45.10 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| HORTON AMY | Officer | 08 Dec 2025 | Sell (-) | 4,572 | 44.07 | 201,488 |
| HOLLOWAY JEAN F | Officer | 03 Dec 2025 | Sell (-) | 7,315 | 45.48 | 332,686 |
| MACKIN JAMES P | Officer | 03 Dec 2025 | Automatic sell (-) | 30,921 | 45.48 | 1,406,287 |
| MACKIN JAMES P | Officer | 03 Dec 2025 | Option execute | 30,921 | - | - |
| MACKIN JAMES P | Officer | 02 Dec 2025 | Automatic sell (-) | 30,921 | 45.37 | 1,402,886 |
| MACKIN JAMES P | Officer | 02 Dec 2025 | Option execute | 30,921 | - | - |
| Date | Type | Details |
|---|---|---|
| 06 Nov 2025 | Announcement | Artivion Reports Third Quarter 2025 Financial Results |
| 06 Nov 2025 | Announcement | Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial |
| 29 Oct 2025 | Announcement | Artivion to Participate in the Stifel 2025 Healthcare Conference |
| 23 Oct 2025 | Announcement | Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results |
| 13 Oct 2025 | Announcement | Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting |
| 5Y Average Dividend Yield | 0.00% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 09 Dec 2015 | 22 Oct 2015 | 18 Dec 2015 | 0.03 Cash |
| 09 Sep 2015 | 22 Jul 2015 | 18 Sep 2015 | 0.03 Cash |
| 10 Jun 2015 | 21 May 2015 | 19 Jun 2015 | 0.03 Cash |
| 11 Mar 2015 | 13 Feb 2015 | 20 Mar 2015 | 0.03 Cash |
| 10 Dec 2014 | 23 Oct 2014 | 19 Dec 2014 | 0.03 Cash |
| 10 Sep 2014 | 30 Jul 2014 | 19 Sep 2014 | 0.03 Cash |
| 11 Jun 2014 | 22 May 2014 | 20 Jun 2014 | 0.03 Cash |
| 12 Mar 2014 | 19 Feb 2014 | 21 Mar 2014 | 0.0275 Cash |
| 11 Dec 2013 | 21 Nov 2013 | 20 Dec 2013 | 0.0275 Cash |
| 11 Sep 2013 | 21 Aug 2013 | 20 Sep 2013 | 0.0275 Cash |
| 12 Jun 2013 | 28 May 2013 | 21 Jun 2013 | 0.0275 Cash |
| 12 Mar 2013 | 13 Feb 2013 | 21 Mar 2013 | 0.025 Cash |
| 12 Dec 2012 | 19 Nov 2012 | 21 Dec 2012 | 0.025 Cash |
| 12 Sep 2012 | 21 Aug 2012 | 21 Sep 2012 | 0.025 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2015 | 0.120 | 4 | 1.11 |
| 2014 | 0.118 | 4 | 1.04 |
| 2013 | 0.108 | 4 | 0.97 |
| 2012 | 0.050 | 2 | 0.80 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |